- Home
- ELTK vs CRVO Comparison
ELTK vs CRVO Comparison
Compare ELTK & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- CRVO
- Stock Information
- Founded
- ELTK 1970
- CRVO 2001
- Country
- ELTK Israel
- CRVO United States
- Employees
- ELTK N/A
- CRVO N/A
- Industry
- ELTK Electrical Products
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- ELTK Technology
- CRVO Health Care
- Exchange
- ELTK Nasdaq
- CRVO Nasdaq
- Market Cap
- ELTK 70.4M
- CRVO 67.4M
- IPO Year
- ELTK 1997
- CRVO N/A
- Fundamental
- Price
- ELTK $10.18
- CRVO $10.12
- Analyst Decision
- ELTK
- CRVO Strong Buy
- Analyst Count
- ELTK 0
- CRVO 6
- Target Price
- ELTK N/A
- CRVO $17.60
- AVG Volume (30 Days)
- ELTK 9.3K
- CRVO 820.1K
- Earning Date
- ELTK 08-14-2025
- CRVO 08-08-2025
- Dividend Yield
- ELTK 1.87%
- CRVO N/A
- EPS Growth
- ELTK N/A
- CRVO N/A
- EPS
- ELTK 0.45
- CRVO N/A
- Revenue
- ELTK $49,563,000.00
- CRVO $7,776,968.00
- Revenue This Year
- ELTK $18.60
- CRVO N/A
- Revenue Next Year
- ELTK $9.04
- CRVO N/A
- P/E Ratio
- ELTK $22.55
- CRVO N/A
- Revenue Growth
- ELTK 6.75
- CRVO N/A
- 52 Week Low
- ELTK $7.65
- CRVO $1.80
- 52 Week High
- ELTK $12.19
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- ELTK 46.22
- CRVO 65.00
- Support Level
- ELTK $10.20
- CRVO $9.11
- Resistance Level
- ELTK $10.45
- CRVO $9.96
- Average True Range (ATR)
- ELTK 0.35
- CRVO 0.79
- MACD
- ELTK -0.01
- CRVO 0.06
- Stochastic Oscillator
- ELTK 27.94
- CRVO 90.31
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.